Kidney Cancer
-
Optimal Duration of Therapy in Metastatic RCC: Exploring Treatment-Free Survival with Checkpoint Inhibitors
Grayce N. Selig, MD1 Christopher J. Hoimes, DO,2 Joe Bible, PhD,3 Daniel J. George, MD,2 Michael R. Harrison, MD2 1. Duke University Medical Center…
Read More » -
Comparison of Papillary Renal Cell Carcinoma Type 1 and Type 2: A Secondary Data Analysis
Melissa Paquin, PhD,1 Tracy Fasolino, PhD, FNP,2 Joe Bible, PhD,3 Mary Beth Steck, PhD,2 Joel Williams, PhD.4 1. Clemson University, Hampton, GA 30228 USA.…
Read More » -
From Gene Discovery to a FDA approval; Belzutifan’s Fascinating Journey at UTSW
Published on: August 21, 2021 A novel kidney cancer drug developed from UT Southwestern Medical Center received approval from the Food…
Read More » -
Keytruda plus Lenvima Combo Received FDA Approval for Advanced Kidney Cancer
August 20, 2021 Frontline Keytruda plus Lenvima for advanced renal cell carcinoma is an effective treatment with life-prolonging benefits, although…
Read More » -
Combo of cabozantinib plus atezolizumab active across kidney cancer subtypes
September 9, 2021 By Gregor Kreth Recent findings based on the phase 1b COSMIC-021 trial in Journal of Clinical Oncology…
Read More » -
US FDA Approves Belzutifan for Tumors Associated With Certain Types of Von Hippel-Lindau Disease
By Gregor Kreth, Guest Writer August 16, 2021 FDA approves Merck’s Welireg for the treatment of adult patients with von…
Read More » -
ASCO21 Meeting Summary – Kidney Cancer
Practice Changing Results in RCC come from ASCO 2021 Ochsner Precision Cancer Therapies Program and Ochsner Cancer Institute, Benson Cancer…
Read More » -
Roundtable Discussion – Cancer and COVID-19
Robert J. Motzer, MD¹, Eric A. Jonasch, MD2,Bradley A. McGregor, MD3, Robert A. Figlin, MD, FACP4 1 Memorial Sloan Kettering…
Read More » -
Editor’s Memo
Robert A. Figlin MD Novel Drug Combinations Gain Traction Across Therapeutic Landscape More than a year since the COVID-19 crisis…
Read More » -
Updated NCCN Guideline Recommends Tivozanib Regimen in Clear Cell Renal Cell Carcinoma
Christoph Baker Mar 29 | 2021 National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines to include FOTIVDA® (tivozanib)…
Read More »
